Recombinant multi-species PCBP4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PCBP4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the KH-domain protein subfamily. Proteins of this subfamily, also referred to as alpha-CPs, bind to RNA with a specificity for C-rich pyrimidine regions. Alpha-CPs play important roles in post-transcriptional activities and have different cellular distributions. This gene is induced by the p53 tumor suppressor, and the encoded protein can suppress cell proliferation by inducing apoptosis and cell cycle arrest in G(2)-M. This gene's protein is found in the cytoplasm, yet it lacks the nuclear localization signals found in other subfamily members. Multiple alternatively spliced transcript variants have been described, but the full-length nature for only some has been determined. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1200003L19Rik,Alpha-CP4,AlphaCP-4,CBP,LIP4,MCG10,PCBP4,Pcbp4,Poly(rC)-binding protein 4

Target products collectionGo to PCBP4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10519-Ag-1/ GM-Tg-hg-IP10519-Ag-2 Human PCBP4 protein Human
GM-Tg-rg-IP10519-Ag-1/ GM-Tg-rg-IP10519-Ag-2 Rat PCBP4 protein Rat
GM-Tg-mg-IP10519-Ag-1/ GM-Tg-mg-IP10519-Ag-2 Mouse PCBP4 protein Mouse
GM-Tg-cynog-IP10519-Ag-1/ GM-Tg-cynog-IP10519-Ag-2 Cynomolgus/Rhesus macaque PCBP4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10519-Ag-1/ GM-Tg-felg-IP10519-Ag-2 Feline PCBP4 protein Feline
GM-Tg-cang-IP10519-Ag-1/ GM-Tg-cang-IP10519-Ag-2 Canine PCBP4 protein Canine
GM-Tg-bovg-IP10519-Ag-1/ GM-Tg-bovg-IP10519-Ag-2 Bovine PCBP4 protein Bovine
GM-Tg-equg-IP10519-Ag-1/ GM-Tg-equg-IP10519-Ag-2 Equine PCBP4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10519-Ag-1/ GM-Tg-hg-IP10519-Ag-2; GM-Tg-rg-IP10519-Ag-1/ GM-Tg-rg-IP10519-Ag-2;
GM-Tg-mg-IP10519-Ag-1/ GM-Tg-mg-IP10519-Ag-2; GM-Tg-cynog-IP10519-Ag-1/ GM-Tg-cynog-IP10519-Ag-2;
GM-Tg-felg-IP10519-Ag-1/ GM-Tg-felg-IP10519-Ag-2; GM-Tg-cang-IP10519-Ag-1/ GM-Tg-cang-IP10519-Ag-2;
GM-Tg-bovg-IP10519-Ag-1/ GM-Tg-bovg-IP10519-Ag-2; GM-Tg-equg-IP10519-Ag-1/ GM-Tg-equg-IP10519-Ag-2
Products Name PCBP4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PCBP4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PCBP4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.